Criticalkare Pharma

Alveofact 50mg Injection contains an active component called Phospholipid fraction from bovine lung. It is used as medication primarily in the treatment of respiratory distress syndrome (RDS) in premature infants. This condition occurs when the lungs don't produce enough surfactant, a substance essential for maintaining the lungs' elasticity and preventing alveoli collapse. In severe cases of pneumonia, especially in premature infants or newborns, where lung function is compromised, this medication might be used to support breathing. In some cases, this medication might assist with lung function when babies pass stool (meconium) while still in the womb and inhale it into their lungs before or during delivery, causing breathing problems.

Uses
Neonatal respiratory distress syndrome (RDS)Meconium aspiration syndromePneumoniaAcute respiratory distress syndrome (ARDS)Lung surfactant deficiency

Storage
Stored at controlled room temperature, between 2°C to 8°C

Side Effects
Airway blockageInfectionAllergic reactionsPulmonary hemorrhageTransient oxygen desaturationChanges in heart rateBreathing difficulties

Alimta 500mg injection is an anticancer medicine containing the active ingredient Pemetrexed.  It belongs to the medication class known as an antifolate agent. It is used to treat non-small cell lung cancer and malignant pleural mesothelioma (cancers of the lungs and chest). This medicine is given alone or in combination with another anticancer medicine, such as cisplatin. Your doctor may prescribe corticosteroids, folic acid, and vitamin B12 to limit the side effects.  
Blood tests will be taken before each infusion to determine whether your kidney and liver functions are adequate and whether you have enough blood cells to receive this medicine. Before starting treatment with Alimta 500mg injection, it is very important to tell your physician if you currently or previously had any medical conditions of kidney problems, heart disorders, or fluid accumulation in the lungs. Report to your doctor if you recently had or currently having radiotherapy or any vaccination before taking this medication.

Uses
Malignant pleural mesotheliomaNon-small cell lung carcinoma

Storage
Store refrigerated at 2°C to 8°C.

Side Effects
Blood infectionSevere allergic reactionBreathlessness, intense chest pain or cough with bloody sputumReduced neutrophil granulocytes (white blood cells)Kidney failurePharyngitis (a sore throat)Abnormal liver functionFatigueNausea, vomiting, diarrheaRedness, swelling or sores in the mouthLoss of appetite, sensationReduced hemoglobin levelIncreased skin pigmentationWatery and inflamed eyes, taste changeFeverMuscle weaknessDehydrationConstipationSkin rashHair loss

Alimta 100mg injection is an anticancer medicine containing the active ingredient Pemetrexed.  It belongs to the medication class known as an antifolate agent. It is used to treat non-small cell lung cancer and malignant pleural mesothelioma (cancers of the lungs and chest). This medicine is given alone or in combination with another anticancer medicine, such as cisplatin. Your doctor may prescribe corticosteroids, folic acid, and vitamin B12 to limit the side effects.  
Blood tests will be taken before each infusion to determine whether your kidney and liver functions are adequate and whether you have enough blood cells to receive this medicine. Before starting treatment with Alimta 100mg injection, it is very important to tell your physician if you currently or previously had any medical conditions of kidney problems, heart disorders, or fluid accumulation in the lungs. Report to your doctor if you recently had or currently having radiotherapy or any vaccination before taking this medication.

Uses
Malignant pleural mesotheliomaNon-small cell lung carcinoma

Storage
Store refrigerated at 2°C to 8°C.

Side Effects
Blood infectionSevere allergic reactionBreathlessness, intense chest pain or cough with bloody sputumReduced neutrophil granulocytes (white blood cells)Kidney failurePharyngitis (a sore throat)Abnormal liver functionFatigueNausea, vomiting, diarrheaRedness, swelling or sores in the mouthLoss of appetite, sensationReduced hemoglobin levelIncreased skin pigmentationWatery and inflamed eyes, taste changeFeverMuscle weaknessDehydrationConstipationSkin rashHair loss

Rybrevant 350mg injection contains the active substance Amivantamab. It is an antineoplastic drug that belongs to the class of medications called bispecific antibodies. It is used to treat a type of cancer called non-small cell lung cancer (NSCLC) that spreads to other parts of the body and has certain changes in a gene called EGFR. It is also used if it cannot be removed by surgery and has worsened during or after treatment with other anticancer medications.
Do not take this injection if you are allergic to amivantamab or any other ingredients of this medicine. Inform your physician if you have suffered from inflammation of your lungs or any other lung conditions before initiating the therapy. Report to your physician if you face any symptoms of sudden difficulty in breathing, cough, or fever that may suggest inflammation of the lungs. Rybrevant 350mg injection is not recommended for children or young people below 18 years of age.
Inform your physician if you have kidney, liver, or lung problems before initiating the therapy. The common side effects of Rybrevant 350mg injection are rash, nail inflammation, musculoskeletal pain, shortness of breath, nausea, fatigue, swelling, an inflamed and sore mouth, cough, constipation, and vomiting. This medicine may cause harm to the fetus; hence, use effective contraception during the treatment.

Uses
Non-small cell lung cancer (NSCLC)

Storage
Store Rybrevant 350mg injection in the refrigerator (2°C to 8°C)Do not freezeKeep the injection away from the reach of children and pets.If you have missed any dosing appointments, inform your doctor and schedule immediately.

Side Effects
Swelling in the face, hands, and feetInflammation in the nailsConstipationNausea, vomitingInflamed and sore mouthMusculoskeletal painCoughShortness of breathTiredness Severe rashes in the skinEye pain and infectionInflammation of the lungsInfusion reactions